1.0Indonesia Tribunehttps://indonesiatribune.comadminhttps://indonesiatribune.com/author/admin/Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study - Indonesia Tribunerich600338<blockquote class="wp-embedded-content" data-secret="Pgji9gd5PM"><a href="https://indonesiatribune.com/curative-biotechnology-announces-completion-of-ind-enabling-reformulated-metformin-hcl-eye-drop-study/">Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://indonesiatribune.com/curative-biotechnology-announces-completion-of-ind-enabling-reformulated-metformin-hcl-eye-drop-study/embed/#?secret=Pgji9gd5PM" width="600" height="338" title="“Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study” — Indonesia Tribune" data-secret="Pgji9gd5PM" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today that it has successfully completed its Investigational New Drug (IND) enabling Tolerance and Toxicology Study of Metformin HCL Solution by Topical […]https://ci4.googleusercontent.com/proxy/LqRkgTbdFDv7Jmyu6VcAWVZfUOm79g5hT3090LUTiEwvWQdfDl2KywDTIuUeTu_GDAGg5ld-OiTOdpWGUusJ4g4iRFSG2hPMbDji8De0QKycxMz7tRwqf6uxj4eVOi-NLnYqP5hmUbnMKydFG7cuSv3qK4m2XLLM1ZvaQMvkQBrxJP3FszFBQzLxZXo2HwYMk8_1j_5Ru3JHSy8M=s0-d-e1-ft#https://ml.globenewswire.com/media/YmU3NDE4MTEtYzFhOS00MTVmLTkzN2ItYjAyZTAwZWEzOGUyLTUwMDA3MDkyNw==/tiny/Curative-Biotechnology-Inc-.png